Prostate Cancer UK Professionals
LightNews LightNews
banner
prostateukprofs.bsky.social
Prostate Cancer UK Professionals
@prostateukprofs.bsky.social
280 followers 440 following 260 posts
Here we share news and views from @ProstateCancerUK for our growing professional community who have an interest in prostate disease 🧑‍🔬⤵️
Posts Replies Media Videos
prostateukprofs.bsky.social
🌟 Ready to lead the change in transforming prostate cancer care?

🚀 Gain crucial leadership and change management skills on our Clinical Champions Programme!

🌐✨ Apply now
Clinical Champions Programme
Our 18-month long programme aims to identify future clinical leaders and provide them with the knowledge and skills to deliver improvements to prostate cancer care.
bit.ly
December 22, 2025 at 11:01 AM
prostateukprofs.bsky.social
In light of the growing body of evidence around screening the APPG on #ProstateCancer we were delighted to hear from experts from within the European Praise-U consortium earlier this year about the approaches and methods being undertaken in other countries.

Read the report here: buff.ly/uqqAMNU
The image shows five professionally dressed adults standing side by side in an indoor, formal setting, posing for a group photograph at what appears to be an official or advocacy-related event. They are wearing business attire, including suits, blazers, and identification lanyards, some marked “Visitor,” suggesting participation in an organised meeting or conference. Behind them is a vertical banner prominently referencing prostate cancer and an organisation focused on improving outcomes for men affected by the disease, clearly indicating the purpose of the gathering. The wooden-paneled background and composed posture of the group give the scene a formal, institutional tone, while their relaxed expressions convey collaboration, solidarity, and shared commitment to prostate cancer awareness and advocacy. The image shows a group of five adults standing together indoors in a formal, professional setting, posing for a group photograph at what appears to be an advocacy or awareness event. All are dressed in smart business or business-casual attire, including suits, collared shirts, and blazers, and several wear orange lanyards with identification badges, indicating official participation or visitor status. Positioned behind them is a tall banner referencing prostate cancer and an organisation focused on improving outcomes for men affected by the disease, clearly establishing the purpose of the gathering. The background features a large abstract artwork in deep red tones, adding visual contrast to the scene, while the group’s relaxed posture and friendly expressions convey collaboration, shared purpose, and support for prostate cancer awareness and engagement.
December 19, 2025 at 3:00 PM
prostateukprofs.bsky.social
The December edition of Research News is here! Find out about:

🔬 An exciting research project.
💻 A new webinar series.
🩺 UK Prostate Cancer Clinical Research Strategy Group.
💬 Discussion session topic at From Ideas to Innovation.

📚 Read it here: buff.ly/kXTXjdx
Professor Johann de Bono and Dr Adam Sharp stand side by side, looking at a computer screen displaying prostate tissue.
December 19, 2025 at 10:30 AM
Reposted by Prostate Cancer UK Professionals
juanjimenezvacas.bsky.social
Excited to share our new study from @asharpmedonc.bsky.social lab at @icr.ac.uk 🔬✨
We identify therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer.
So happy to have to co-led this work with my colleagues and friends #DanWestaby & @inesfigueiredo.bsky.social
🔗 bit.ly/4oHSvNx
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer
Targeting anti-apoptotic BCL2 family proteins is an attractive therapeutic strategy to drive prostate cancer (PCa) cell death. Here, we show that MCL1 is highly expressed in castration-resistant PCa (...
www.cell.com
November 14, 2025 at 8:43 PM
prostateukprofs.bsky.social
Could targeting MCL1 & BCLXL be effective in advanced #ProstateCancer?

Research in @cp-iscience.bsky.social led by Dr Westaby, @juanjimenezvacas.bsky.social, @asharpmedonc.bsky.social & Prof de Bono, supported by our Movember London Centre of Excellence.

Grab a ☕ & read: doi.org/10.1016/j.is...
Scientific Paper published in iScience, titled: Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer. Written by Westaby et al.
December 16, 2025 at 5:45 PM
prostateukprofs.bsky.social
Upcoming webinar: Augmented SBRT & precision in prostate cancer treatment.

Hear about current approaches, practical considerations developments within this area.

📅 Jan 28
⏰ 3:00–4:30 CEST
📍 Zoom

Register: bit.ly/492iMjT
Webinar advertisement for "Augmented SBRT: Accuracy in Prostate Cancer Treatment" on January 28, 2026, featuring speakers Prof. Piet Oost, Dr. Stefano Arcoangel, and moderator Prof. Duncan McLaren. Includes a QR code for registration, hosted by Micropos Medical, with a dark blue background and light text.
December 15, 2025 at 3:21 PM
prostateukprofs.bsky.social
Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.

🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.
Man in a white shirt wearing a Prostate Cancer UK pin badge, speaking on a phone, with text 'Our new Black Men's One-to-One Support Service'.
December 14, 2025 at 7:11 PM
prostateukprofs.bsky.social
🖥️ Don't miss the next webinar from the European Prostate Cancer Alliance on 'Tumour heterogeneity and molecular imaging', featuring Prostate Cancer UK funded researchers Professor Hing Leung and Professor Craig Robson.

📆 15th December
⏰ 15:00 - 17:15
🔗 t.co/ejVkwgiij9
December 11, 2025 at 4:30 PM
prostateukprofs.bsky.social
Dr Joaquin Mateo was a research fellow @icr.ac.uk interested in making personalised #ProstateCancer treatments.

In 2014, we funded him to see if men with specific DNA mutations responded favourably to a drug called olaparib.

📙 Read more: prostatecanceruk.org/research/res...
December 10, 2025 at 5:30 PM
prostateukprofs.bsky.social
Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer?

A team including Prostate Cancer UK funded Dr Ke Yuan @uofgcancersciences.bsky.social take protein language models a step forward in @natcomms.nature.com.

Grab a ☕ and read: doi.org/10.1038/s414...
December 9, 2025 at 5:01 PM
prostateukprofs.bsky.social
If you’re a Black healthcare professional, we want to help you drive change in prostate cancer care.

Our Clinical Champions Programme will support you to become a transformative leader and make a lasting impact.

Apply now 👉
Clinical Champions Programme
Our 18-month long programme aims to identify future clinical leaders and provide them with the knowledge and skills to deliver improvements to prostate cancer care.
bit.ly
December 9, 2025 at 10:30 AM
prostateukprofs.bsky.social
🗣️ YOUR FEEDBACK MATTERS

Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.

Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
Close-up of an individual using a laptop, focusing on the face and hand. The person is wearing a black shirt with pins, including a crown and a red cross.
December 6, 2025 at 1:24 PM
prostateukprofs.bsky.social
Screening takes time but early diagnosis can’t wait.

Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources.

Sign up to our health professional e-newsletter ➡️ bit.ly/2VktI7b
Infographic by Prostate Cancer UK illustrating the current diagnostic pathway for prostate cancer, including steps from PSA blood test, MRI scan, to targeted transperineal biopsy, followed by diagnosis.
December 5, 2025 at 4:15 PM
prostateukprofs.bsky.social
Ready to lead impactful change? Apply now to be a part of our award-winning 18-month flagship programme.

🌟Apply now: bit.ly/46I5Fn9
Group photo of various health professionals in front of a building, everyone is smiling.
December 5, 2025 at 2:02 PM
prostateukprofs.bsky.social
📣 We’re looking forward to the discussion session at From Ideas to Innovation, which will explore Equity in Research Career Progression.

🙏We’re grateful to our research community for sharing their insights and experiences.

⬇️ Check out the full agenda.

prostatecanceruk.org/research/for...
I'm excited to take part in this discussion because it offers an inclusive space to openly explore ideas, share challenges and opportunities in research career progression, and work together to drive meaningful change. Dr Uzoamaka Okoli, University College London.
December 5, 2025 at 8:01 AM
prostateukprofs.bsky.social
🥼 Meet Prof Hashim Ahmed and Prof Mark Emberton, researchers and clinicians dedicated to improving the way we diagnose men with prostate cancer.

Find out more ➡️ bit.ly/3xSHfYS
Image featuring portraits of Professors Hashim Ahmed and Mark Emberton, co-leads of the TRANSFORM trial. The text discusses their hopes of revolutionising prostate cancer diagnosis and treatment through the trial. Both are dressed professionally, with Ahmed in surgical attire and Emberton in a suit.
December 4, 2025 at 4:15 PM
prostateukprofs.bsky.social
🥼 Meet Dr Bunmi Olajide, a GP dedicated to improving cancer care and raising awareness of Black men’s higher risk of prostate cancer.

Learn more ➡️ bit.ly/4ip3ysp
Image of Dr. Bunmi Olajide, a GP (primary care clinician), wearing glasses and a suit, with a quote about the importance of early detection of prostate cancer to improve treatment outcomes.
December 3, 2025 at 7:01 PM
prostateukprofs.bsky.social
🗣️ YOUR FEEDBACK MATTERS

Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.

Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
Close-up of an individual using a laptop, focusing on the face and hand. The person is wearing a black shirt with pins, including a crown and a red cross.
December 3, 2025 at 8:00 AM
prostateukprofs.bsky.social
Could dose–response model parameters influence identification of bladder regions vulnerable to radiotherapy-induced toxicity?

A team led by Dr Tanuj Puri, Prof Marcel van Herk & Dr Alan McWilliam @manchester.ac.uk share new findings in Physica Medica.

Grab a ☕ & read: doi.org/10.1016/j.ej...
Scientific Paper published in Physica Medica, titled: Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy. Written by Puri et al.
December 2, 2025 at 5:00 PM
prostateukprofs.bsky.social
While the NSC has recommended screening only for men with BRCA gene variations, this isn’t the end of the story.

Our ongoing research, including TRANSFORM, will provide the evidence needed to expand screening safely in the future.

Find out more ➡️ bit.ly/3xSHfYS
TRANSFORM trial
The £42 million TRANSFORM trial, the biggest prostate cancer screening trial in 20 years, could save the lives of thousands of men each year.
bit.ly
December 2, 2025 at 4:02 PM
prostateukprofs.bsky.social
🗣️ YOUR FEEDBACK MATTERS

Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations.

Please complete this form to help us understand how best to support you and your patients ➡️ bit.ly/4pGzzyH
Close-up of an individual using a laptop, focusing on the face and hand. The person is wearing a black shirt with pins, including a crown and a red cross.
December 1, 2025 at 5:07 PM
prostateukprofs.bsky.social
Friday’s NSC recommendation is a step toward targeted prostate cancer screening for men with BRCA gene variations.

However, many men at higher risk are being missed.

Read more about the recent announcement here➡️ bit.ly/4ip3ysp
Infographic by Prostate Cancer UK illustrating prostate cancer risk factors. It shows that 1 in 8 men will get prostate cancer, with higher risks for individuals over 50, those with a family history, Black individuals, and those with BRCA gene variations.
December 1, 2025 at 3:19 PM
prostateukprofs.bsky.social
Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience.

🩵 Please signpost men in your care to bit.ly/47yAMke or our phone line 0800 448 0745 to self-refer.
Man in a white shirt wearing a Prostate Cancer UK pin badge, speaking on a phone, with text 'Our new Black Men's One-to-One Support Service'.
December 1, 2025 at 12:02 PM
prostateukprofs.bsky.social
Thank you to all the researchers, clinicians and health professionals who continue to drive progress in early prostate cancer diagnosis 🩵

Your work is helping shape the evidence and care that will save more men’s lives.

Read more about it here👉 buff.ly/OojAs47
November 28, 2025 at 4:42 PM
prostateukprofs.bsky.social
🚨 BREAKING NEWS

The UK NSC has announced support for targeted prostate cancer screening for men with BRCA gene variations. A step forward in earlier detection for men at highest risk.

Read our co-signed statement here ➡️ buff.ly/nXIirI0
November 28, 2025 at 3:10 PM